KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Invested Capital (2016 - 2025)

West Pharmaceutical Services' Return on Invested Capital history spans 16 years, with the latest figure at 0.26% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 11.0% year-over-year to 0.26%; the TTM value through Dec 2025 reached 0.26%, up 11.0%, while the annual FY2025 figure was 0.3%, 15.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.26% at West Pharmaceutical Services, up from 0.15% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.26% in Q4 2025 and bottomed at 0.15% in Q3 2025.
  • The 5-year median for Return on Invested Capital is 0.19% (2023), against an average of 0.2%.
  • The largest annual shift saw Return on Invested Capital decreased -7bps in 2023 before it grew 11bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.26% in 2021, then fell by -14bps to 0.22% in 2022, then fell by -17bps to 0.18% in 2023, then decreased by -12bps to 0.16% in 2024, then soared by 66bps to 0.26% in 2025.
  • Per Business Quant, the three most recent readings for WST's Return on Invested Capital are 0.26% (Q4 2025), 0.15% (Q3 2025), and 0.15% (Q2 2025).